Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,454,563
  • Shares Outstanding, K 198,999
  • Annual Sales, $ 78,890 K
  • Annual Income, $ 29,400 K
  • 60-Month Beta 1.06
  • Price/Sales 70.60
  • Price/Cash Flow N/A
  • Price/Book 23.99
Trade PACB with:

Options Overview Details

View History
  • Implied Volatility 68.66%
  • Historical Volatility 46.05%
  • IV Percentile 23%
  • IV Rank 15.43%
  • IV High 129.52% on 03/05/21
  • IV Low 57.55% on 06/21/21
  • Put/Call Vol Ratio 2.04
  • Today's Volume 1,599
  • Volume Avg (30-Day) 2,817
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 22,020
  • Open Int (30-Day) 22,381

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.21
  • Number of Estimates 3
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.70 +2.17%
on 09/16/21
32.55 -16.19%
on 09/01/21
-0.72 (-2.57%)
since 08/20/21
3-Month
25.24 +8.08%
on 07/19/21
36.36 -24.97%
on 06/29/21
-2.97 (-9.82%)
since 06/22/21
52-Week
8.05 +238.88%
on 09/24/20
53.69 -49.19%
on 02/11/21
+18.50 (+210.53%)
since 09/22/20

Most Recent Stories

More News
PacBio (PACB) Closes Omniome Buyout, Forays Into San Diego

PacBio's (PACB) latest acquisition is expected to deliver a differentiated set of products and applications across a wide spectrum of markets.

HSIC : 76.86 (+1.76%)
IDXX : 671.47 (+0.69%)
PACB : 27.28 (-0.47%)
NVTA : 31.73 (-0.19%)
Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence

Omniome's high accuracy short-read sequencing platform expected to significantly expand PacBio's market opportunity

PACB : 27.28 (-0.47%)
A Second Week of Declines as September Continues

A Second Week of Declines as September Continues

SATS : 26.03 (+0.77%)
ROKU : 324.77 (+1.81%)
PXD : 150.05 (+1.42%)
FISV : 108.69 (+2.33%)
TWST : 120.92 (+0.78%)
PACB : 27.28 (-0.47%)
NVTA : 31.73 (-0.19%)
CRSP : 117.81 (+0.48%)
Single Cell Genome Sequencing Market: Product Specification, Share, Size, Emerging Trends, Competitive Analysis and Forecast 2028

Research Nester published a report titled which delivers detailed overview of the global single cell genome sequencingmarket in terms of market segmentation by product, application, end user and by region....

QGEN : 54.75 (-0.15%)
A : 172.44 (+0.58%)
TMO : 606.63 (+1.61%)
ILMN : 434.59 (-0.04%)
BIO : 785.64 (+0.02%)
PACB : 27.28 (-0.47%)
Long Read Sequencing Market: Future Trends, Growing Demand, Analysis, Forecast & Industry Developments to 2028

Research Nester has released a report titled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness,...

PACB : 27.28 (-0.47%)
QGEN : 54.75 (-0.15%)
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences

Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences:

PACB : 27.28 (-0.47%)
Pacific Biosciences (PACB) Down 0.1% Since Last Earnings Report: Can It Rebound?

Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PACB : 27.28 (-0.47%)
Here's Why You Should Retain PacBio (PACB) Stock For Now

Investors continue to be optimistic about PacBio (PACB) owing to its slew of strategic deals and strength in its Sequel system.

ISRG : 1,028.47 (+1.42%)
HSIC : 76.86 (+1.76%)
IDXX : 671.47 (+0.69%)
PACB : 27.28 (-0.47%)
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conference

Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conference:

PACB : 27.28 (-0.47%)
S&P, NASDAQ Set New Highs While Waiting for Jobs Report

S&P, NASDAQ Set New Highs While Waiting for Jobs Report

RXT : 14.10 (-0.35%)
MTRN : 68.72 (+0.70%)
CRSP : 117.81 (+0.48%)
BEAM : 95.47 (+0.54%)
APLS : 32.42 (-1.61%)
NTLA : 149.05 (+0.89%)
ONCT : 4.20 (unch)
EDIT : 59.11 (+0.73%)
PACB : 27.28 (-0.47%)
CCRN : 20.88 (+2.81%)
ALTO : 4.67 (-1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed...

See More

Key Turning Points

3rd Resistance Point 29.26
2nd Resistance Point 28.83
1st Resistance Point 28.05
Last Price 27.28
1st Support Level 26.84
2nd Support Level 26.41
3rd Support Level 25.63

See More

52-Week High 53.69
Fibonacci 61.8% 36.26
Fibonacci 50% 30.87
Last Price 27.28
Fibonacci 38.2% 25.48
52-Week Low 8.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar